Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB

Clinical trial NCT01320943 · COMPLETED

Trial details

NCT number: NCT01320943
Sponsor: Gilead Sciences
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Chronic Hepatitis B

Start date: 2011-04-26
Primary completion: 2016-07-28
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.